Migraine in Children
14
3
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
83.3%
-3.2% vs benchmark
7%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
nVNS for the Prevention and Treatment of Primary Headache
Supraspinal Processing of Sensory Aspects of Pain
Uric Acid Levels and Migraine in Children
A Survey Study to Assess the Accessibility of the Nerivio Device At School
Association of Helicobacter Pylori Infection and Migraine
Intravenous Fluids in Pediatric Migraine
A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab
Aerobic Exercise and Neck Exercises in Pediatric Migraine Treatment
Tryptophan Metabolites in Pediatric Migraine
SPG Block for Acute Pediatric Migraine
Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
Mindfulness for Adolescents for CM and HFEM
A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine
Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients